Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab
Trial Number
NCT02891824 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Recurrent Ovarian
Lead Cooperative Group
Participating Groups
AGO
BGOG
ISGO
AGO-AUST
CEEGOG